Abstract Dual-phase [18 F] AV45 positron emission tomography (PET) is highly promising in
the assessment of neurodegenerative diseases, allowing to obtain information on both …

Abstract Purpose [18F]-D3FSP is a new β-amyloid (Aβ) PET imaging tracer designed to
decrease nonspecific signals in the brain by reducing the formation of the N-demethylated …

Purpose 18F-APN-1607 is a novel tau positron emission tomography (PET) tracer
characterized with high binding affinity for 3− and 4-repeat tau deposits. The aim was to …

Importance Tau positron emission tomography (PET) tracers have proven useful for the
differential diagnosis of dementia, but their utility for predicting cognitive change is unclear …

Purpose [18 F] FDG is a commonly used neuronal injury biomarker for early and differential
diagnosis of dementia. Typically, the blood supply to the brain is closely coupled to glucose …

Background: Florbetapir (AV45) and fluorodeoxyglucose (FDG) PET imaging are valuable
techniques to detect the amyloid-β (Aβ) load and brain glucose metabolism in patients with …

Purpose We aimed to identify the cortical regions where hypometabolism can predict the
speed of conversion to dementia in mild cognitive impairment due to Alzheimer's disease …

Purpose To assess the clinical utility of 18F-Fluorodeoxyglucose positron emission
tomography (FDG-PET) for detection of early signs of neurodegeneration in conditions of …

Objective Detection of focal brain tau deposition during life could greatly facilitate accurate
diagnosis of Alzheimer disease (AD), staging and monitoring of disease progression, and …

Background: Current research diagnostic criteria for Alzheimer's disease (AD) and mild
cognitive impairment (MCI) due to AD include biomarkers to supplement clinical testing …